Vanguard Group Inc Allena Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.02 - $0.23 $53,642 - $616,893	-2,682,145 Closed	0 $0
Q2 2022 Aug 12, 2022	BUY	$0.08 - $0.26 $8,076 - $26,247	100,952 Added 3.91%	2,682,145 $512,000
Q1 2022 May 13, 2022	SELL	$0.23 - $0.65 $163,199 - $461,215	-709,562 Reduced 21.56%	2,581,193 $597,000
Q4 2021 Feb 14, 2022	BUY	$0.59 - $1.0 $757,397 - $1.28 Million	1,283,724 Added 63.96%	3,290,755 $1.95 Million
Q3 2021 Nov 12, 2021	BUY	$0.78 - $1.39 $35,791 - $63,782	45,887 Added 2.34%	2,007,031 $1.81 Million

Q2 2021 Aug 13, 2021	BUY	$1.08 - $1.38 $2.12 Million - $2.71 Million	1,961,144 New	1,961,144 $2.55 Million

Ticker ALNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 122,083,000
Market Cap $9.16M
Description
Allena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. Its lead product candidate is ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and gout in the setting...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.